Documents
Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS
04 July 2004
This report provides data on the different sources and price ranges of HIV/AIDS drugs. It documents marketing information to help procurement agencies make informed decisions on the source of drugs; manufacturers interested in supplying HIV-related drugs and diagnostics at reduced prices; and the availability and price range of antiretroviral drugs for combination therapy. The report also includes information on essential drugs used to treat a wide range of opportunistic infections, pain-relieving drugs for use in palliative care, and drugs for the treatment of HIV/AIDS-related cancer. For the first time, it provides information on the range of test kits available for the diagnosis of HIV.
Related
What the data tell us: Projections for the HIV epidemic in western and central Europe and North America in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in the Middle East and North Africa in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in eastern Europe and central Asia in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in Asia and the Pacific in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in western and central Africa in 2030
28 March 2025
What the data tell us: Projections for the HIV epidemic in eastern and southern Africa in 2030
28 March 2025
U=U can help end HIV stigma and discrimination. Here’s how

27 February 2025